On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Clusterin in disease pathology

TopicLeading institutions, researchers & key papers

Clusterin in disease pathology is a topic indexed in ScholarIQ from OpenAlex.

What is known about Clusterin in disease pathology?

ScholarIQrecord summary

This cluster of papers explores the multifaceted role of Clusterin, a chaperone protein, in cancer development, progression, and therapy. It investigates its involvement in apoptosis inhibition, TGF-ß signaling modulation, angiogenesis promotion, chemoresistance, and its potential as a biomarker for various cancers. The papers also discuss the implications of Clusterin in metastasis, particularly in prostate cancer.

How many works does Clusterin in disease pathology have?

ScholarIQindexed works

Clusterin in disease pathology has 37 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Clusterin in disease pathology?

ScholarIQopenalex

The OpenAlex for Clusterin in disease pathology is on the source record.

What are the most-cited papers on Clusterin in disease pathology?

ScholarIQmost cited works
Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis
Satoshi Serada, Minoru Fujimoto, Fumitaka Terabe, Hideki Iijima, Shinichiro Shinzaki, Shinya Matsuzaki, Tomoharu Ohkawara, Riichiro Nezu, Sachiko Nakajima, Taku Kobayashi, Scott E. Plevy, Tetsuo Takehara, Tetsuji Naka
Inflammatory Bowel Diseases. 2012230 CitationsOPEN ACCESS
iTRAQ-based proteomic identification of leucine-rich α-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases
Satoshi Serada, Minoru Fujimoto, Atsushi Ogata, Fumitaka Terabe, Toru Hirano, Hideki Iijima, Shinichiro Shinzaki, Teppei Nishikawa, Tomoharu Ohkawara, Kota Iwahori, Nobuyuki Ohguro, T Kishimoto, Tetsuji Naka
Annals of the Rheumatic Diseases. 2009222 Citations
Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis
Shinichiro Shinzaki, Katsuyoshi Matsuoka, Hideki Iijima, Shinta Mizuno, Satoshi Serada, Minoru Fujimoto, Norimitsu Arai, Noriyuki Koyama, Eiichi Morii, Mamoru Watanabe, Toshifumi Hibi∥, Takanori Kanai∥, Tetsuo Takehara, Tetsuji Naka
Journal of Crohn s and Colitis. 2016156 CitationsOPEN ACCESS
Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease
Eriko Yasutomi, Toshihiro Inokuchi, Sakiko Hiraoka, Kensuke Takei, Shoko Igawa, Shumpei Yamamoto, Masayasu Ohmori, Shohei Oka, Yasushi Yamasaki, Hideaki Kinugasa, Masahiro Takahara, Keita Harada, Masaki Furukawa, Kouichi Itoshima, Ken Okada, Fumio Otsuka, Takehiro Tanaka, Toshiharu Mitsuhashi, Jun Kato, Hiroyuki Okada
Scientific Reports. 202184 CitationsOPEN ACCESS
Temperature-Sensitive Polymer-Coated Magnetic Nanoparticles as a Potential Drug Delivery System for Targeted Therapy of Thyroid Cancer
Bhanu Koppolu, Zarna Bhavsar, Aniket S. Wadajkar, Sivaniarvindpriya Nattama, Maham Rahimi, Fiemu E. Nwariaku, Kytai T. Nguyen
Journal of Biomedical Nanotechnology. 201263 Citations

Where is Clusterin in disease pathology research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Clusterin in disease pathology is open access?

ScholarIQopen access share
57%OPEN ACCESS
Gold
14%
Green
0%
Hybrid
29%
Bronze
14%
Closed
43%

Related on ScholarIQ

470M+ articles · 14-day free trial